Thailand - Stop TB Partnership

Notes
1. United Nations Development Programme (UNDP), Human Development Report 2004, (New York:
UNDP, 2004), pp. 140, 185.
2. See, e.g. Achieving the Millennium Development Goals: the Middle Income Countries, British Department
for International Development (DFID), August 2004, p. 19, available at: www.dfid.gov.uk/pubs/files/
achievingmdgmidincome.pdf (accessed February 5, 2006).
3. Bureau of Policy and Strategy, Ministry of Public Health (MoPH), Health Policy in Thailand, 2003, p. 7.
4. Mahidol Population Gazette, January 2005; Vol. 14.
5. Department of Communicable Disease Control, MoPH, Thailand and World Health Organization
(WHO), Second Review of the National Tuberculosis Programme in Thailand, (Geneva: WHO, 1999), p. 9.
6. TB Division, MoPH, Battle Against TB (National Tuberculois Programme, 1999).
7. WHO, Global Tuberculosis Control: Surveillance, Planning, Financing, (Geneva: WHO, 2006), p. 122.
8. Written comments on a draft of this report by Jay Varma, section chief for TB Prevention and Control
of the Thailand–U.S. Collaboration (TUC) and internist and epidemiologist, U.S. Centers for Disease
Control and Prevention, Bangkok, December 2005.
9. WHO, Global Tuberculosis Control: Surveillance, Planning, Financing, (Geneva: WHO, 2006), p. 131.
10. Department of Communicable Disease Control, MoPH and WHO, Second Review of the National
Tuberculosis Programme in Thailand, 1999, p. 3.
11. Kaiser Family Foundation, “Thailand to Offer TB Treatment as Part of HIV/AIDS Treatment Program,”
(Washington, D.C.: August 4, 2005) available at www.kaisernetwork.org (accessed August 4, 2005).
12. M. Perkins and P. Small, “Admitting Defeat,” International Journal of Tuberculosis and Lung Disease,
2006; 10 (1): 1.
13. The same study showed that resistance to individual drugs ranged from 5.96 percent for isoniazid
(INH) to 2.2 percent for rifampicin. WHO, 1996–1998.
14. WHO, Global Tuberculosis Control: Surveillance, Planning Financing, (Geneva: WHO, 2006), p. 122.
15. Comments by Thai experts at roundtable meetings supported by Public Health Watch in Bangkok and
Chiang Mai, December 9 and 12, 2005.
16. MoPH, Bureau of Policy and Strategy, 2003, Health Policy in Thailand 2003, p. 7.
17. Written comments on a draft of this report by Jay Varma, section chief for TB Prevention and Control
of the Thailand–U.S. Collaboration (TUC) and internist and epidemiologist, U.S. Centers for Disease
Control and Prevention, Bangkok, December 2005. The study was carried out in four regions of
Thailand: Bangkok, Chiangrai (in the north), Phuket (in the south), and Ubol Ratchatani (in the
northeast).
18. Written comments on a draft of this report by Jay Varma, section chief for TB Prevention and Control
of the Thailand–U.S. Collaboration (TUC) and internist and epidemiologist, U.S. Centers for Disease
Control and Prevention, Bangkok, December 2005.
19. Interview with Attapon Cheepsattayakorn, director of the 10th TB Zonal Tuberculosis and Chest
Disease Center, December 2005.
20. Comment by Samran Takan, director of New Life Friend Center, Public Health Watch roundtable
meeting, Chiang Mai, December 9, 2005.
21. MoPH, Thailand Health Profile, 1999-2000, Thailand, MoPH, 2002.
22. Somsak Akksilp, director, Office of Disease Prevention and Control Region 7.
23. National Health Security Office, Annual Report 2004, Progress and Achievement, 2004, p. 10.
24. Interview with Sirinapha Jittimanee, public health officer, TB Cluster, Bureau of AIDS, TB and STIs
December 7, 2005.
72
TB POLICY IN THAILAND